本文へ移動
cccskills
無料GitHub で公開

pediatric-obesity-consultation

Guide a non-stigmatising pediatric obesity consultation using the 5As framework (Ask, Assess, Advise, Agree, Assist) and 4Ms assessment (Metabolic, Mechanical, Mental Health, Social Milieu), based on the CMAJ 2025 guideline. Trigger when a clinician asks how to approach a weight conversation with a child or family, how to use the 5As for obesity, how to assess a child with obesity, or how to conduct a non-judgmental obesity visit.

インストール方法を見る

含まれるファイル(1)

  • SKILL.md6.9 KB

SKILL.md(原文)

インストールする前に、エージェントに与えられる指示の中身を確認できます。

Pediatric Obesity: Non-Stigmatising Consultation (5As + 4Ms)

A step-by-step guide for conducting a pediatric obesity consultation that supports shared decision-making, reduces stigma, and leads to an actionable management plan.

Based on CMAJ 2025 Clinical Practice Guideline (Ball et al., doi: 10.1503/cmaj.241456) and the 5As of Pediatric Obesity Management framework.


Before You Start — Language Checklist

Use person-first, weight-neutral language throughout the visit:

Instead of...Say...
"Obese child""Child with obesity"
"Fat" / "overweight""BMI", "weight", "growth"
"You need to lose weight""Let's talk about your health and how you're feeling"
"This is caused by poor diet""Obesity has many causes — genetics, environment, and more"
"You just need to exercise more""Physical activity is one part of a bigger picture"

Step 1 — ASK (Permission and Setting)

Before any weight-related conversation, ask permission.

  • "Would it be okay if we talked about your health and weight today?"
  • "Some families prefer to discuss this privately — would you like [child/caregiver] to step out for part of our conversation?"

Decide who is in the room:

  • Young children: caregiver-led conversation
  • Adolescents: consider child-only portion + caregiver-only portion + together
  • Default: include both, but follow the child's preference

If the family declines the conversation today: Respect that. Document and offer to revisit.


Step 2 — ASSESS (4Ms Framework)

Work through all four domains systematically:

Metabolic

  • Blood pressure (hypertension risk)
  • Fasting glucose / insulin / HOMA-IR (insulin resistance, pre-diabetes, T2DM)
  • Fasting lipids: TG, HDL-C, LDL-C, total cholesterol
  • ALT (non-alcoholic fatty liver disease)
  • BMIz using WHO criteria and sex- and age-specific charts
  • Obstructive sleep apnea symptoms (snoring, daytime sleepiness, apnoeic episodes)

Mechanical

  • Musculoskeletal pain (knees, back, hips — common in childhood obesity)
  • Exercise tolerance and physical activity barriers
  • Mobility (does weight affect play, sports, daily activities?)

Mental Health (do not skip)

  • Depression and anxiety (use validated screen: e.g., PHQ-A, GAD-7 for adolescents)
  • Eating disorder screen: binge eating, restriction, purging, compensatory behaviours
  • Body image concerns and weight-based self-esteem
  • Bullying (weight-based teasing is common and has lasting effects)
  • Caregiver mental health (parental stress, anxiety, depression can affect child outcomes)

Social Milieu

  • Food security (access to nutritious food at home)
  • Neighbourhood safety (affects outdoor activity, active transportation)
  • Screen time patterns
  • Family routines (mealtimes, sleep schedule, activity norms)
  • Cultural factors affecting diet and body image
  • Access to health care and obesity management services

📋 Document findings across all 4Ms — this forms the basis of your intervention plan.


Step 3 — ADVISE (Present Options Without Bias)

Present all three categories of intervention — do not withhold any option:

  1. Behavioural and psychological interventions — multicomponent programs (physical activity + nutrition + psychology); available in most settings
  2. Pharmacotherapy — GLP-1RAs, metformin (age ≥12); always combined with behavioural therapy
  3. Surgical interventions — LSG or RYGB (age ≥13, specialised centres); conditional on multidisciplinary assessment

⚠️ No stepwise hierarchy is required — present all options and let the family's values and circumstances guide selection. There is no mandate to "fail" behavioural therapy before pharmacotherapy or surgery.

For each option, communicate:

  • What the intervention involves
  • Expected benefits (with honest magnitude: often small to moderate for most outcomes)
  • Expected harms and side effects
  • Availability and access issues (cost, wait times, geography)

Step 4 — AGREE (Shared Decision-Making)

Work with the child and family to align on:

  • Goals that matter to them — not just BMI reduction. Ask:
    • "What would you most like to be different about your health?"
    • "What activities do you wish you could do that feel hard right now?"
    • Common priorities: energy levels, mood, mobility, peer relationships, sleep
  • Preferred intervention(s) based on the discussion above
  • Realistic expectations — obesity is chronic and relapsing; success is not linear
  • Roles and responsibilities — who does what (child, caregiver, clinician, team)

Document the agreed plan explicitly, including what will be tried and the follow-up timeline.


Step 5 — ASSIST (Connect and Support)

Provide tangible next steps before the family leaves:

  • Referrals: Dietitian, kinesiologist, psychologist, social worker, paediatric obesity program (as needed)
  • Resources: Casebook for health care providers; guide for caregivers (Obesity Canada / Obesity Canada–OC)
  • Follow-up appointment: Book before they leave — long-term support is essential
  • If surgical referral indicated: Initiate multidisciplinary assessment process
  • If pharmacotherapy agreed: Prescribe + enrol in/confirm behavioural program simultaneously

⚠️ Remind the family: obesity requires long-term management. You and your team are partners in this — it is not the family's "fault" and not their problem to solve alone.


Clinical Guardrails

  • Eating disorder vigilance throughout: Monitor at every visit. If screening suggests risk → refer to specialist before or instead of standard obesity interventions
  • Don't focus on weight alone. Improved HRQoL, mood, energy, and cardiometabolic markers are valid and often more meaningful outcomes for families
  • Acknowledge stigma explicitly: Many families have had negative experiences with healthcare. Naming this builds trust
  • Social determinants are modifiable — refer accordingly. Food bank referral, community programs, social worker involvement
  • Technology-only approaches: Insufficient evidence — do not use as a standalone
  • Transition to adult care: Begin planning from age 16; obesity does not resolve at 18

Source

CMAJ 2025 Clinical Practice Guideline: Managing obesity in children. Ball GDC et al. CMAJ 2025 April 14; 197:E372–89. doi: 10.1503/cmaj.241456 5As of Pediatric Obesity Management: Vallis et al. / Obesity Canada. Updated version: June 3, 2025.

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

同じリポジトリのスキル

概要と使いどころ

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

dromlakhani のスキルをすべて見る

このスキルの問題を報告する